The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils - PubMed (original) (raw)

Affiliations

PMID: 8186324

Comparative Study

The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils

J K Jenkins et al. Lymphokine Cytokine Res. 1994 Feb.

Abstract

LPS stimulates human monocytes and neutrophils to produce IL-1 beta and IL-1 receptor antagonist (IL-1ra). IL-10 has been shown to inhibit LPS-induced IL-1 beta production in human monocytes. The objective of these studies was to examine the effects of IL-10 on human monocyte and neutrophil IL-1ra protein and mRNA production and compare it to IL-1 beta. IL-10 markedly inhibited LPS-induced IL-1 beta mRNA and protein production in both cell types. IL-10 alone induced IL-1ra mRNA production in monocytes with a low level of protein production. Furthermore, IL-10 led to enhanced levels of IL-1ra mRNA in LPS-induced monocytes at 2 to 6 h and of IL-1ra protein at 4-16 h, but there was no increase in levels of IL-1ra protein at 24 h or later. In neutrophils IL-10 alone did not stimulate IL-1ra protein or mRNA production and did not augment LPS-induced IL-1ra mRNA. These net effects of IL-10 resulted in an increase in the ratio of IL-1ra to IL-1 beta in both neutrophils and monocytes. The net effects of IL-10 on inflammatory cells may be important in modulation of biologic responses to IL-1.

PubMed Disclaimer

Cited by

[Intra-articular therapy with autologous interleukin-1 receptor antagonist in osteoarthritis. Innovation or quackery?].
Stengel D, Ekkernkamp A, Wich M. Stengel D, et al. Unfallchirurg. 2004 Nov;107(11):1103-6. doi: 10.1007/s00113-004-0885-9. Unfallchirurg. 2004. PMID: 15517132 German. No abstract available.
Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist.
Phillips WG, Feldmann M, Breathnach SM, Brennan FM. Phillips WG, et al. Clin Exp Immunol. 1995 Jul;101(1):177-82. doi: 10.1111/j.1365-2249.1995.tb02295.x. Clin Exp Immunol. 1995. PMID: 7621586 Free PMC article.
A Novel Fusion of IL-10 Engineered to Traffic across Intestinal Epithelium to Treat Colitis.
Fay NC, Muthusamy BP, Nyugen LP, Desai RC, Taverner A, MacKay J, Seung M, Hunter T, Liu K, Chandalia A, Coyle MP, Kim HL, Postlethwaite S, Mangat K, Song L, Seto E, Alam A, Olson CV, Feng W, Saberi M, Mahmood TA, Mrsny RJ. Fay NC, et al. J Immunol. 2020 Dec 1;205(11):3191-3204. doi: 10.4049/jimmunol.2000848. Epub 2020 Nov 4. J Immunol. 2020. PMID: 33148717 Free PMC article.
An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.
Kutwin M, Migdalska-Sęk M, Brzeziańska-Lasota E, Zelga P, Woźniacka A. Kutwin M, et al. J Clin Med. 2021 Dec 13;10(24):5834. doi: 10.3390/jcm10245834. J Clin Med. 2021. PMID: 34945130 Free PMC article.
Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome.
Botto S, Abraham J, Mizuno N, Pryke K, Gall B, Landais I, Streblow DN, Fruh KJ, DeFilippis VR. Botto S, et al. mBio. 2019 Feb 12;10(1):e02510-18. doi: 10.1128/mBio.02510-18. mBio. 2019. PMID: 30755509 Free PMC article.

The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils - PubMed (original) (raw)